| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 33 |
| 1 | ALENDRONATE SODIUM | 33 |
| 2 | METHOTREXATE SODIUM | 31 |
| 3 | METHOTREXATE | 29 |
| 4 | ASPIRIN | 27 |
| 5 | ASPIRIN 325 MG | 27 |
| 6 | ASPIRIN 81 MG | 27 |
| 7 | ERGOCALCIFEROL | 25 |
| 8 | OMEPRAZOLE MAGNESIUM | 23 |
| 9 | PREDNISONE | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACTAMINOPHEN | 1 | 0.0667 |
| 1 | METEX | 3 | 0.0079 |
| 2 | ALUMINUM CHLORIDE | 1 | 0.0066 |
| 3 | NEOSTIGMINE METHYLSULFATE | 2 | 0.0046 |
| 4 | COSYNTROPIN | 1 | 0.0045 |
| 5 | DIFLUNISAL | 3 | 0.0037 |
| 6 | ACONITUM NAPELLUS, AESCULUS HIPPOCASTANUM, FLOS, ARSENICUM ALBUM, AVENA SATIVA, BELLADONNA, CAMPHORA, CINCHONA OFFICINALIS, COFFEA CRUDA, CYPRIPEDIUM PUBESCENS, HYOSCYAMUS NIGER, IGNATIA AMARA, KALI PHOSPHORICUM, PASSIFLORA INCARNATA, PHOSPHORUS, PULSATILLA, AND VALERIANA OFFICINALIS. | 1 | 0.0036 |
| 7 | MINERAL OIL, WHITE PETROLATUM | 1 | 0.0035 |
| 8 | CETYLPYRIDINIUM CHLORIDE | 2 | 0.0031 |
| 9 | SODIUM MONOFLUOROPHOSPHATE | 1 | 0.0027 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 71 |
| 1 | Corticosteroid [EPC] | 68 |
| 2 | Benzodiazepine [EPC] | 38 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 29 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 28 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 27 |
| 6 | Aromatase Inhibitor [EPC] | 25 |
| 7 | Provitamin D2 Compound [EPC] | 25 |
| 8 | Proton Pump Inhibitor [EPC] | 24 |
| 9 | Mood Stabilizer [EPC] | 21 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 3 | Provitamin D2 Compound [EPC] | 25 | 0.0008 |
| 4 | Photoenhancer [EPC] | 2 | 0.0005 |
| 5 | Benzothiazole [EPC] | 1 | 0.0004 |
| 6 | Bismuth [EPC] | 2 | 0.0004 |
| 7 | Thyroid Hormone Synthesis Inhibitor [EPC] | 3 | 0.0003 |
| 8 | Estrogen Receptor Antagonist [EPC] | 12 | 0.0003 |
| 9 | Anti-coagulant [EPC] | 1 | 0.0003 |